Skip to main content
. 2021 Dec 14;12:757014. doi: 10.3389/fgene.2021.757014

FIGURE 1.

FIGURE 1

The expression of FAM20C in different types of cancer, including glioma. (A) The expression of FAM20C in different types of cancer cells was obtained from the CCLE database, including glioma (n = 66), chondrosarcoma (n = 4), mesothelioma (n = 11), meningioma (n = 3), kidney (n = 37), upper aerodigestive (n = 33), thyroid (n = 12), giant cell tumour (n = 3), melanoma (n = 63), soft tissue (n = 20), neuroblastoma (n = 17), breast (n = 60), osteosarcoma (n = 10), liver (n = 29), esophagus (n = 27), Ewing’s sarcoma (n = 12), medulloblastoma (n = 4), bile duct (n = 8), lung NSC (n = 136), pancreas (n = 46), ovary (n = 55), urinary tract (n = 28), endometrium (n = 28), prostate (n = 8), lung small cell (n = 54), stomach (n = 39), acute myeloid leukemia (n = 39), leukemia other (n = 5), lymphoma Hodgkin (n = 13), colorectal (n = 63), B cell acute lymphoblastic leukemia (n = 13), T cell acute lymphoblastic leukemia (n = 16), chronic myelogenous leukemia (n = 15), lymphoma DLBCL (n = 18), multiple myeloma (n = 29), B cell lymphoma other (n = 16), T cell lymphoma other (n = 11), and lymphoma Burkitt (n = 11); (B) the expression of FAM20C in different types of cancer was obtained from Tumor Immune Estimation Resource database, including ACC (n = 77), BLCA (n = 423), BRCA (n = 1197), CESC (n = 309), CHOL (n = 45), COAD (n = 316), DLBC (n = 47), ESCA (n = 195), GBM (n = 163), HNSC (n = 563), KICH (n = 91), KIRC (n = 595), KIRP (n = 318), LAML (n = 173), brain LGG (n = 518), LIHC (n = 419), LUAD (n = 542), LUSC (n = 542), MESO (n = 87), OV (n = 426), PAAD (n = 183), PCPG (n = 185), PRAD (n = 544), READ (n = 102), SARC (n = 264), SKCM (n = 462), STAD (n = 444), TGCT (n = 137), THCA (n = 571), THYM (n = 120), UCEC (n = 187), UCS (n = 57), and UVM (n = 79). *p < 0.05; ***p < 0.001.